Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.
from CBC | Health News https://ift.tt/3tElWDm
Aucun commentaire:
Enregistrer un commentaire